Valuation: BAYER

Market Cap 49.04B 55.91B 45.42B 41.79B 79.05B 5,352B 80.59B 541B 212B 2,628B 210B 205B 9,076B P/E 2026 *
21.1x
P/E 2027 * 15.8x
Enterprise Value 80.79B 92.11B 74.83B 68.85B 130B 8,816B 133B 892B 350B 4,329B 346B 338B 14,951B EV / Sales 2026 *
1.77x
EV / Sales 2027 * 1.66x
Free-Float
100%
Yield 2026 *
0.47%
Yield 2027 * 1.28%
Manager TitleAgeSince
Chief Executive Officer 59 31/05/2023
Director of Finance/CFO 57 31/05/2026
Chief Tech/Sci/R&D Officer 59 31/01/2021
Director TitleAgeSince
Director/Board Member 56 31/03/2012
Director/Board Member 66 31/03/2022
Director/Board Member 60 31/03/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.24%-6.82%+44.03%+156.15% 1,054B
-1.65%-5.31%+61.36%+58.28% 621B
-1.06%-3.87%+27.81%+79.98% 438B
-1.12%-3.68%+26.89%+20.58% 325B
-1.73%-3.45%+26.95%+44.09% 281B
-1.95%-13.92%+15.96%+19.76% 262B
-1.45%-2.37%-27.87%-39.87% 219B
-0.98%-3.09%+20.10%+56.86% 195B
-0.51%-4.50%+16.18%+68.71% 163B
Average -1.47%-1.70%+23.49%+51.62% 395.13B
Weighted average by Cap. -1.68%-1.69%+33.07%+76.92%

Financials

2026 *2027 *
Net sales 45.59B 51.98B 42.22B 38.85B 73.48B 4,975B 74.91B 503B 197B 2,443B 195B 191B 8,437B 46.72B 53.26B 43.27B 39.81B 75.3B 5,098B 76.77B 516B 202B 2,503B 200B 196B 8,645B
Net income 2.17B 2.47B 2.01B 1.85B 3.49B 236B 3.56B 23.92B 9.38B 116B 9.28B 9.07B 401B 2.99B 3.41B 2.77B 2.55B 4.82B 326B 4.91B 33.02B 12.95B 160B 12.81B 12.53B 554B
Net Debt 31.75B 36.2B 29.4B 27.05B 51.17B 3,464B 52.17B 350B 137B 1,701B 136B 133B 5,875B 28.53B 32.53B 26.42B 24.31B 45.99B 3,113B 46.88B 315B 124B 1,529B 122B 119B 5,280B
Logo BAYER
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-